Literature DB >> 19165171

Liver NF-kappaB and AP-1 DNA binding in obese patients.

Luis A Videla1, Gladys Tapia, Ramón Rodrigo, Paulina Pettinelli, Daniela Haim, Catherine Santibañez, A Verónica Araya, Gladys Smok, Attila Csendes, Luis Gutierrez, Jorge Rojas, Jaime Castillo, Owen Korn, Fernando Maluenda, Juan C Díaz, Guillermo Rencoret, Jaime Poniachik.   

Abstract

Oxidative stress and insulin resistance (IR) are major contributors in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and in the progression from steatosis to nonalcoholic steatohepatitis (NASH). Our aim was to assess nuclear factor-kappaB (NF-kappaB) and activating protein-1 (AP-1) activation and Toll-like receptor 4 (TLR4) expression as signaling mechanisms related to liver injury in obese NAFLD patients, and examined potential correlations among them, oxidative stress, and IR. Liver NF-kappaB and AP-1 (electromobility shift assay (EMSA)), TLR4 expression (western blot), ferric reducing ability of plasma (FRAP), and IR evolution (HOMA) were evaluated in 17 obese patients who underwent subtotal gastrectomy with gastro-jejunal anastomosis in Roux-en-Y and 10 nonobese subjects who underwent laparoscopic cholecystectomy (controls). Liver NF-kappaB and AP-1 DNA binding were markedly increased in NASH patients (n = 9; P < 0.05) compared to controls, without significant changes in NAFLD patients with steatosis (n = 8), whereas TLR4 expression was comparable between groups. Hepatic NF-kappaB activation was positively correlated with that of AP-1 (r = 0.79; P < 0.0001); both liver NF-kappaB and AP-1 DNA binding were inversely associated with FRAP (r = -0.43 and r = -0.40, respectively; P < 0.05) and directly correlated with HOMA (r = 0.66 and r = 0.62, respectively, P < 0.001). Data presented show enhanced liver activation of the proinflammatory transcription factors NF-kappaB and AP-1 in obese patients with NASH, parameters that are significantly associated to oxidative stress and IR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165171     DOI: 10.1038/oby.2008.601

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  30 in total

1.  Mouse Models of Bariatric Surgery.

Authors:  Deng Ping Yin; Kelli L Boyd; Phillip E Williams; Naji N Abumrad; David H Wasserman
Journal:  Curr Protoc Mouse Biol       Date:  2012-12-01

Review 2.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Gregory J Gores
Journal:  Clin Lipidol       Date:  2010-02-01

4.  CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.

Authors:  Guangzhi Chen; Renfan Xu; Shasha Zhang; Yinna Wang; Peihua Wang; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-11-11       Impact factor: 4.310

5.  Obesity enhances sepsis-induced liver inflammation and injury in mice.

Authors:  Jennifer M Kaplan; Marchele Nowell; Patrick Lahni; Hui Shen; Shiva K Shanmukhappa; Basilia Zingarelli
Journal:  Obesity (Silver Spring)       Date:  2016-05-13       Impact factor: 5.002

6.  Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms.

Authors:  Luis A Videla
Journal:  World J Hepatol       Date:  2009-10-31

Review 7.  NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

Authors:  Tom Luedde; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

8.  TLR4 and Insulin Resistance.

Authors:  Jane J Kim; Dorothy D Sears
Journal:  Gastroenterol Res Pract       Date:  2010-08-10       Impact factor: 2.260

9.  Increased expression of c-Jun in nonalcoholic fatty liver disease.

Authors:  Christoph Dorn; Julia C Engelmann; Michael Saugspier; Andreas Koch; Arndt Hartmann; Martina Müller; Rainer Spang; Anja Bosserhoff; Claus Hellerbrand
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

10.  Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.

Authors:  Jinhui Li; Teryn N Sapper; Eunice Mah; Swetha Rudraiah; Kevin E Schill; Chureeporn Chitchumroonchokchai; Meredith V Moller; Joshua D McDonald; Philip R Rohrer; José E Manautou; Richard S Bruno
Journal:  Mol Nutr Food Res       Date:  2016-02-18       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.